 Connection
Jesse Schold to End Stage Liver Disease
This is a "connection" page, showing publications Jesse Schold has written about End Stage Liver Disease.
|
|
| |
Connection Strength |
|
 |
|
 |
| |
2.076 |
|
|
|
-
Jackson WE, Lopez R, Forman LM, Arrigain S, Schold JD. Marked variation in disease acuity and outcomes on the liver transplant waiting list by sociodemographic characteristics. Liver Transpl. 2025 May 01; 31(5):584-595.
Score: 0.835
-
Forman LM, Jackson WE, Arrigain S, Lopez R, Schold JD. Socioeconomic deprivation is associated with worse patient and graft survival following adult liver transplantation. Liver Transpl. 2025 Feb 01; 31(2):211-220.
Score: 0.814
-
Malamon JS, Kaplan B, Jackson WE, Saben JL, Schold JD, Pomfret EA, Pomposelli JJ. Reassessing the survival benefit of deceased donor liver transplantation: retrospective cohort study. Int J Surg. 2023 Sep 01; 109(9):2714-2720.
Score: 0.194
-
Jackson WE, Malamon JS, Kaplan B, Saben JL, Schold JD, Pomposelli JJ, Pomfret EA. Survival Benefit of Living-Donor Liver Transplant. JAMA Surg. 2022 10 01; 157(10):926-932.
Score: 0.182
-
Wehrle CJ, Gross A, Fares S, Kusakabe J, Calderon E, Shanmugarajah K, Uysal M, Fleischer CM, Allkushi E, Schold JD, Khalil M, Pita A, Fujiki M, Schlegel A, Miller C, Hashimoto K, Wakam GK. Changing Landscape of Open Offers in Liver Transplantation in the Machine Perfusion Era: Exposure, Equity, and Economics. Clin Transplant. 2024 Oct; 38(10):e70012.
Score: 0.052
|
Connection Strength
The connection strength for concepts is the sum of the scores for each matching publication.
Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.
|